Emcure Pharmaceuticals Limited (NSE:EMCURE)
India flag India · Delayed Price · Currency is INR
1,560.00
+38.90 (2.56%)
Mar 10, 2026, 9:40 AM IST

Emcure Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Market Capitalization
288,385203,202----
Upgrade
Enterprise Value
301,271214,615----
Upgrade
Last Close Price
1521.101070.19----
Upgrade
PE Ratio
33.1429.82----
Upgrade
Forward PE
26.2224.17----
Upgrade
PS Ratio
3.262.57----
Upgrade
PB Ratio
5.904.38----
Upgrade
P/TBV Ratio
7.735.81----
Upgrade
P/FCF Ratio
-32.26----
Upgrade
P/OCF Ratio
-23.86----
Upgrade
PEG Ratio
0.970.93----
Upgrade
EV/Sales Ratio
3.402.72----
Upgrade
EV/EBITDA Ratio
17.6215.20----
Upgrade
EV/EBIT Ratio
23.4019.79----
Upgrade
EV/FCF Ratio
-34.07----
Upgrade
Debt / Equity Ratio
0.340.220.750.881.051.04
Upgrade
Debt / EBITDA Ratio
0.970.701.911.991.681.93
Upgrade
Debt / FCF Ratio
-1.622.846.555.694.26
Upgrade
Net Debt / Equity Ratio
0.240.170.600.710.970.84
Upgrade
Net Debt / EBITDA Ratio
0.690.561.581.651.591.60
Upgrade
Net Debt / FCF Ratio
-1.262.275.305.273.43
Upgrade
Asset Turnover
-0.990.920.940.910.79
Upgrade
Inventory Turnover
-1.801.661.541.471.39
Upgrade
Quick Ratio
-0.860.750.720.510.58
Upgrade
Current Ratio
-1.711.331.271.161.09
Upgrade
Return on Equity (ROE)
-18.23%18.28%23.59%31.35%27.90%
Upgrade
Return on Assets (ROA)
-8.45%7.92%9.04%10.54%9.43%
Upgrade
Return on Invested Capital (ROIC)
15.83%15.16%13.97%15.92%18.40%16.42%
Upgrade
Return on Capital Employed (ROCE)
-19.50%20.00%25.20%35.00%28.40%
Upgrade
Earnings Yield
3.02%3.35%----
Upgrade
FCF Yield
-3.10%----
Upgrade
Dividend Yield
0.21%0.28%----
Upgrade
Payout Ratio
--10.89%6.80%8.19%4.61%
Upgrade
Buyback Yield / Dilution
-2.49%-3.41%-0.01%---
Upgrade
Total Shareholder Return
-2.28%-3.13%-0.01%---
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.